
David Guzo
Examiner (ID: 9040)
| Most Active Art Unit | 1636 |
| Art Unit(s) | 1636, 1805, 2899 |
| Total Applications | 1205 |
| Issued Applications | 693 |
| Pending Applications | 160 |
| Abandoned Applications | 352 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 496415
[patent_doc_number] => 07208296
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-04-24
[patent_title] => 'Method for producing L-glutamic acid by fermentation accompanied by precipitation'
[patent_app_type] => utility
[patent_app_number] => 11/150265
[patent_app_country] => US
[patent_app_date] => 2005-06-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 10
[patent_no_of_words] => 10735
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 195
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/208/07208296.pdf
[firstpage_image] =>[orig_patent_app_number] => 11150265
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/150265 | Method for producing L-glutamic acid by fermentation accompanied by precipitation | Jun 12, 2005 | Issued |
Array
(
[id] => 867488
[patent_doc_number] => 07364740
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-04-29
[patent_title] => 'Molecular differences between species of the M. tuberculosis complex'
[patent_app_type] => utility
[patent_app_number] => 11/143401
[patent_app_country] => US
[patent_app_date] => 2005-06-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12095
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/364/07364740.pdf
[firstpage_image] =>[orig_patent_app_number] => 11143401
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/143401 | Molecular differences between species of the M. tuberculosis complex | May 31, 2005 | Issued |
Array
(
[id] => 5894356
[patent_doc_number] => 20060002895
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-01-05
[patent_title] => 'Induction of apoptic or cytotoxic gene expression by adenoviral mediated gene codelivery'
[patent_app_type] => utility
[patent_app_number] => 11/141678
[patent_app_country] => US
[patent_app_date] => 2005-05-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 36155
[patent_no_of_claims] => 69
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0002/20060002895.pdf
[firstpage_image] =>[orig_patent_app_number] => 11141678
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/141678 | Induction of apoptic or cytotoxic gene expression by adenoviral mediated gene codelivery | May 30, 2005 | Abandoned |
Array
(
[id] => 5799257
[patent_doc_number] => 20060034804
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-02-16
[patent_title] => 'Adenoviral vectors having a protein IX deletion'
[patent_app_type] => utility
[patent_app_number] => 11/130594
[patent_app_country] => US
[patent_app_date] => 2005-05-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 23
[patent_no_of_words] => 16594
[patent_no_of_claims] => 41
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0034/20060034804.pdf
[firstpage_image] =>[orig_patent_app_number] => 11130594
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/130594 | Adenoviral vectors having a protein IX deletion | May 15, 2005 | Abandoned |
Array
(
[id] => 6931246
[patent_doc_number] => 20050282281
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-12-22
[patent_title] => 'Recombinant baculoviral vector containing protein transduction domain gene'
[patent_app_type] => utility
[patent_app_number] => 11/128539
[patent_app_country] => US
[patent_app_date] => 2005-05-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 1483
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0282/20050282281.pdf
[firstpage_image] =>[orig_patent_app_number] => 11128539
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/128539 | Recombinant baculoviral vector containing protein transduction domain gene | May 12, 2005 | Abandoned |
Array
(
[id] => 6944794
[patent_doc_number] => 20050196843
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-09-08
[patent_title] => 'Recombinant cell clones having increased stability and methods of making and using the same'
[patent_app_type] => utility
[patent_app_number] => 11/123362
[patent_app_country] => US
[patent_app_date] => 2005-05-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 6873
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0196/20050196843.pdf
[firstpage_image] =>[orig_patent_app_number] => 11123362
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/123362 | Recombinant cell clones having increased stability and methods of making and using the same | May 5, 2005 | Issued |
Array
(
[id] => 826772
[patent_doc_number] => 07402436
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-07-22
[patent_title] => 'Lentiviral vectors for site-specific gene insertion'
[patent_app_type] => utility
[patent_app_number] => 11/121354
[patent_app_country] => US
[patent_app_date] => 2005-05-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 11247
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/402/07402436.pdf
[firstpage_image] =>[orig_patent_app_number] => 11121354
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/121354 | Lentiviral vectors for site-specific gene insertion | May 2, 2005 | Issued |
Array
(
[id] => 7172037
[patent_doc_number] => 20050203023
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-09-15
[patent_title] => 'Use of rAFP inhibit or prevent apoptosis'
[patent_app_type] => utility
[patent_app_number] => 11/120753
[patent_app_country] => US
[patent_app_date] => 2005-05-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 2708
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0203/20050203023.pdf
[firstpage_image] =>[orig_patent_app_number] => 11120753
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/120753 | Use of rAFP inhibit or prevent apoptosis | May 1, 2005 | Abandoned |
Array
(
[id] => 5766702
[patent_doc_number] => 20060018881
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-01-26
[patent_title] => 'Coordinate in vivo gene expression'
[patent_app_type] => utility
[patent_app_number] => 11/115425
[patent_app_country] => US
[patent_app_date] => 2005-04-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 29
[patent_figures_cnt] => 29
[patent_no_of_words] => 25871
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0018/20060018881.pdf
[firstpage_image] =>[orig_patent_app_number] => 11115425
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/115425 | Coordinate in vivo gene expression | Apr 26, 2005 | Abandoned |
Array
(
[id] => 5709989
[patent_doc_number] => 20060051334
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-03-09
[patent_title] => 'Injection of bone marrow-derived conditioned medium for angiogenesis'
[patent_app_type] => utility
[patent_app_number] => 11/117607
[patent_app_country] => US
[patent_app_date] => 2005-04-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 15729
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0051/20060051334.pdf
[firstpage_image] =>[orig_patent_app_number] => 11117607
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/117607 | Injection of bone marrow-derived conditioned medium for angiogenesis | Apr 26, 2005 | Abandoned |
Array
(
[id] => 6931228
[patent_doc_number] => 20050282263
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-12-22
[patent_title] => 'Flexible vaccine assembly and vaccine delivery platform'
[patent_app_type] => utility
[patent_app_number] => 11/090497
[patent_app_country] => US
[patent_app_date] => 2005-03-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 44
[patent_figures_cnt] => 44
[patent_no_of_words] => 22942
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 18
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0282/20050282263.pdf
[firstpage_image] =>[orig_patent_app_number] => 11090497
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/090497 | Flexible vaccine assembly and vaccine delivery platform | Mar 24, 2005 | Abandoned |
Array
(
[id] => 7111206
[patent_doc_number] => 20050208661
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-09-22
[patent_title] => 'Baculovirus vector, method of producing thereof and method of gene transfer'
[patent_app_type] => utility
[patent_app_number] => 11/086372
[patent_app_country] => US
[patent_app_date] => 2005-03-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 6967
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0208/20050208661.pdf
[firstpage_image] =>[orig_patent_app_number] => 11086372
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/086372 | Baculovirus vector, method of producing thereof and method of gene transfer | Mar 22, 2005 | Issued |
Array
(
[id] => 7216445
[patent_doc_number] => 20050260162
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-11-24
[patent_title] => 'Conditionally replicative adenovirus to target the Rb and Rb-related pathways'
[patent_app_type] => utility
[patent_app_number] => 11/080248
[patent_app_country] => US
[patent_app_date] => 2005-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 22
[patent_no_of_words] => 32284
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0260/20050260162.pdf
[firstpage_image] =>[orig_patent_app_number] => 11080248
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/080248 | Conditionally replicative adenovirus to target the Rb and Rb-related pathways | Mar 14, 2005 | Abandoned |
Array
(
[id] => 7004579
[patent_doc_number] => 20050169892
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-08-04
[patent_title] => 'Adeno-associated virus materials and methods'
[patent_app_type] => utility
[patent_app_number] => 11/063903
[patent_app_country] => US
[patent_app_date] => 2005-02-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 7054
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0169/20050169892.pdf
[firstpage_image] =>[orig_patent_app_number] => 11063903
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/063903 | Adeno-associated virus materials and methods | Feb 22, 2005 | Issued |
Array
(
[id] => 5874429
[patent_doc_number] => 20060166363
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-07-27
[patent_title] => 'Modified baculovirus expression system for production of pseudotyped rAAV vector'
[patent_app_type] => utility
[patent_app_number] => 11/043658
[patent_app_country] => US
[patent_app_date] => 2005-01-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 12976
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0166/20060166363.pdf
[firstpage_image] =>[orig_patent_app_number] => 11043658
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/043658 | Modified baculovirus expression system for production of pseudotyped rAAV vector | Jan 25, 2005 | Abandoned |
Array
(
[id] => 7196838
[patent_doc_number] => 20050164389
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-07-28
[patent_title] => 'Method of using fish plasma components for tissue culture'
[patent_app_type] => utility
[patent_app_number] => 11/019083
[patent_app_country] => US
[patent_app_date] => 2004-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 4907
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0164/20050164389.pdf
[firstpage_image] =>[orig_patent_app_number] => 11019083
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/019083 | Method of using fish plasma components for tissue culture | Dec 20, 2004 | Abandoned |
Array
(
[id] => 7039330
[patent_doc_number] => 20050158764
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-07-21
[patent_title] => 'Recombinant bHLH-PAS/JHR polypeptide and its use to screen potential insecticides'
[patent_app_type] => utility
[patent_app_number] => 11/015354
[patent_app_country] => US
[patent_app_date] => 2004-12-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 22
[patent_no_of_words] => 19983
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0158/20050158764.pdf
[firstpage_image] =>[orig_patent_app_number] => 11015354
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/015354 | Recombinant bHLH-PAS/JHR polypeptide and its use to screen potential insecticides | Dec 16, 2004 | Abandoned |
Array
(
[id] => 5767910
[patent_doc_number] => 20060019393
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-01-26
[patent_title] => 'Minimal lentiviral vector system'
[patent_app_type] => utility
[patent_app_number] => 11/003967
[patent_app_country] => US
[patent_app_date] => 2004-12-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 24
[patent_no_of_words] => 7908
[patent_no_of_claims] => 63
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0019/20060019393.pdf
[firstpage_image] =>[orig_patent_app_number] => 11003967
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/003967 | Minimal lentiviral vector system | Dec 2, 2004 | Abandoned |
Array
(
[id] => 7175942
[patent_doc_number] => 20050123517
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-06-09
[patent_title] => 'Methods for producing and using in vivo pseudotyped retroviruses using envelope glycoproteins from lymphocytic choriomeningitis virus (LCMV)'
[patent_app_type] => utility
[patent_app_number] => 10/993319
[patent_app_country] => US
[patent_app_date] => 2004-11-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 21732
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0123/20050123517.pdf
[firstpage_image] =>[orig_patent_app_number] => 10993319
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/993319 | Methods for producing and using in vivo pseudotyped retroviruses using envelope glycoproteins from lymphocytic choriomeningitis virus (LCMV) | Nov 18, 2004 | Issued |
Array
(
[id] => 7178252
[patent_doc_number] => 20050123998
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-06-09
[patent_title] => 'C5a receptor'
[patent_app_type] => utility
[patent_app_number] => 10/984898
[patent_app_country] => US
[patent_app_date] => 2004-11-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 12632
[patent_no_of_claims] => 53
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0123/20050123998.pdf
[firstpage_image] =>[orig_patent_app_number] => 10984898
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/984898 | C5a receptor | Nov 9, 2004 | Abandoned |